What are the factors that can simply estimate the therapeutic effects of 5a reductase inhibitors in patients with male LUTS?

Matsukawa Y1, Funahashi Y1, Sassa N1, Yoshino Y1, Yamamoto T1, Gotoh M1

Abstract Category

Benign Prostatic Hyperplasia (BPH)

Abstract 377
Non Discussion Poster
Scientific Non Discussion Poster Session 34
Benign Prostatic Hyperplasia (BPH) Bladder Outlet Obstruction Pharmacology
1. Department of Urology, Nagoya University Graduate School of Medicine, Japan